Outcome of Non-Invasive Ventilation in Severe Corona Virus Disease of 2019 Patients; A Prospective Cohort Study

A. Pak, Inst Med Sci, R. Tahir, Adnan Manzar, Ammarah Mehmood, Umer Mehmood, Aitzaz Khan
{"title":"Outcome of Non-Invasive Ventilation in Severe Corona Virus Disease of 2019 Patients; A Prospective Cohort Study","authors":"A. Pak, Inst Med Sci, R. Tahir, Adnan Manzar, Ammarah Mehmood, Umer Mehmood, Aitzaz Khan","doi":"10.48036/apims.v18i3.658","DOIUrl":null,"url":null,"abstract":"Objective: To determine the Outcome of non-invasive ventilation in patients with severe COVID-19 pneumonia.\nMethodology: A prospective cohort study was conducted at Pak Emirates Military Hospital, Rawalpindi, from 1st June to 1st Dec 2021. This study included 87 patients between the ages of 45 and 75 who were admitted due to severe acute respiratory syndrome coronavirus 2 (SARSCoV2) infection.Infection was confirmed by SARS-COV-2 PCR (polymerase Chain reaction). These patients were symptomatic with radiological evidence consistent with COVID-19 pneumonia requiring non-invasive ventilation (NIV) trial. The primary outcome was to analyze the success and failure of using NIV, the need for invasive ventilation, as well as the mortality rate. SPSS 21 was used to enter and analyze the data.\nResults: The mean age was 62.89 ±7.55 years. There were 65(74.7%) males and 22(25.3%) females. NIV was successful in 33 (37.9%) patients, while 54 (62.1%) patients required endotracheal intubation (invasive ventilation). Out of these 54 patients, 44 (81.4%) died after intubation. The mean duration of NIV support was observed as 6.2 ± 3.9 days.\nConclusion: NIV can prevent intubation in less than half of the patients, according to our findings.","PeriodicalId":184398,"journal":{"name":"Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University","volume":"51 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48036/apims.v18i3.658","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To determine the Outcome of non-invasive ventilation in patients with severe COVID-19 pneumonia. Methodology: A prospective cohort study was conducted at Pak Emirates Military Hospital, Rawalpindi, from 1st June to 1st Dec 2021. This study included 87 patients between the ages of 45 and 75 who were admitted due to severe acute respiratory syndrome coronavirus 2 (SARSCoV2) infection.Infection was confirmed by SARS-COV-2 PCR (polymerase Chain reaction). These patients were symptomatic with radiological evidence consistent with COVID-19 pneumonia requiring non-invasive ventilation (NIV) trial. The primary outcome was to analyze the success and failure of using NIV, the need for invasive ventilation, as well as the mortality rate. SPSS 21 was used to enter and analyze the data. Results: The mean age was 62.89 ±7.55 years. There were 65(74.7%) males and 22(25.3%) females. NIV was successful in 33 (37.9%) patients, while 54 (62.1%) patients required endotracheal intubation (invasive ventilation). Out of these 54 patients, 44 (81.4%) died after intubation. The mean duration of NIV support was observed as 6.2 ± 3.9 days. Conclusion: NIV can prevent intubation in less than half of the patients, according to our findings.
2019年重症冠状病毒病无创通气疗效观察一项前瞻性队列研究
目的:探讨无创通气治疗重症COVID-19肺炎的效果。方法:一项前瞻性队列研究于2021年6月1日至12月1日在拉瓦尔品第的巴基斯坦阿联酋军事医院进行。本研究纳入87例因严重急性呼吸综合征冠状病毒2 (SARSCoV2)感染而入院的患者,年龄在45至75岁之间。采用SARS-COV-2聚合酶链反应(PCR)证实感染。这些患者的症状与影像学证据符合COVID-19肺炎,需要无创通气(NIV)试验。主要结果是分析使用NIV的成功和失败,有创通气的需要以及死亡率。采用SPSS 21进行数据录入和分析。结果:患者平均年龄62.89±7.55岁。男性65例(74.7%),女性22例(25.3%)。NIV成功33例(37.9%),54例(62.1%)患者需要气管插管(有创通气)。54例患者中,44例(81.4%)在插管后死亡。NIV支持的平均时间为6.2±3.9天。结论:根据我们的研究结果,NIV可以预防不到一半的患者插管。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信